One of these studies used positron emission tomography (PET) and (18)F (Roselli et al., 2010) MPPF, a selective serotonin 1A receptor antagonist, to investigate whether changes in this receptor activity at the postsynaptic site were involved in the pathophysiology of depression. This evidence concerns the gene HTR1A and depressive symptom measurement.